Go to the list of all blogs
Allana's Avatar
published in Blogs
Oct 24, 2026
TickeronGET DAILY SIGNALS
SCHD ETF Delivers +6% Return Over the Past 30 Days

SCHD ETF Delivers +6% Return Over the Past 30 Days

Key Takeaways

  • SCHD is a passively managed exchange-traded fund (ETF) that tracks the Dow Jones U.S. Dividend 100 Index, holding roughly 102 large-cap, financially screened, dividend-paying U.S. equities.
  • The portfolio is tilted toward consumer staples, healthcare, technology, and energy, with top positions including Texas Instruments, Qualcomm, Procter & Gamble, Chevron, and Coca-Cola.
  • The fund carries a low 0.06% expense ratio and approximately $107.9 billion in assets under management (AUM), reflecting its popularity among income-oriented investors.
  • Over the past 30 days, SCHD advanced about 6%, while its trailing three-month gain stands near 7.5%, consistent with a modest rebound in value and dividend segments.
  • Principal opportunities center on resilient cash flows and shareholder payouts, while key risks include interest-rate sensitivity and sector concentration in cyclical energy.
  • For additional detail on valuation levels and forward expectations, explore the Price Targets and Forecast pages.
  • Readers seeking systematic trading ideas can also review Trending AI Robots.

SCHD ETF Overview

SCHD seeks investment results that correspond to the total return of the Dow Jones U.S. Dividend 100 Index, a benchmark constructed to favor companies with a record of consistent dividend payments, strong balance sheets, and robust free cash flow. The fund is a rules-based, passively managed product that weights holdings by market capitalization within that dividend-quality screen. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

The portfolio holds approximately 102 securities. Its largest positions include TXN, QCOM, PG, CVX, and KO, alongside Merck, UnitedHealth Group, ConocoPhillips, Verizon Communications, and Amgen. Sector allocation is concentrated in consumer staples (near 20%), healthcare (roughly 19%), technology (about 16%), and energy (roughly 16%), with smaller positions in financial services, industrials, consumer discretionary, and communication services. The expense ratio of 0.06% is among the lowest in the dividend-ETF category.

Industry and Thematic Landscape

SCHD operates at the intersection of several durable investment themes: income generation, large-cap value, and quality. Its dividend-quality screen emphasizes companies with sustainable payout ratios and strong fundamentals, which has historically positioned the fund as a defensive complement to growth-oriented portfolios. The portfolio's meaningful energy weighting also ties it to the commodity cycle, while its staples and healthcare exposure provides relatively steady demand characteristics.

The broader macroeconomic backdrop remains relevant to this positioning. Elevated interest rates raise the opportunity cost of holding dividend-paying equities relative to fixed income, yet they also reward companies with pricing power and healthy balance sheets. Inflation trends, monetary policy expectations, and corporate earnings durability continue to shape how investors weigh income-producing assets against higher-growth alternatives.

Performance and Positioning Snapshot

Over the last 30 days, SCHD has advanced approximately 6%, while its trailing three-month performance stands near 7.5%. This movement has been gradual and range-bound rather than sharply trend-driven, consistent with a period of rotation back toward value and dividend-paying segments after a stretch of growth-stock leadership. From what I see, the rebound reflects several identifiable drivers.

Strength in large-cap technology holdings such as Texas Instruments and Qualcomm has supported returns, while stabilizing energy prices and resilient consumer-staples demand have lent ballast. Healthcare names, a core sleeve of the fund, have contributed steady performance. Because SCHD's holdings are weighted toward mature, cash-generative businesses, the fund tends to lag in aggressive rallies and to hold up relatively better when risk appetite cools—behavior evident in its recent steadier path higher. I also checked this using Tickeron’s AI Screener to confirm the sector rotation patterns.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to shape SCHD's trajectory through 2026. Interest-rate policy remains central: falling yields typically improve the relative appeal of dividend strategies, while persistently higher rates can weigh on valuation multiples for income equities. Inflation dynamics and the pace of economic growth will also matter, as they influence both consumer-staples demand and energy prices, two meaningful sleeves of the portfolio.

Earnings cycles among the fund's largest holdings—particularly semiconductor, energy, and pharmaceutical companies—will be an important swing factor. Capital flows into and out of dividend ETFs, competition from higher-yielding fixed income, and regulatory or policy developments affecting healthcare and energy are additional considerations. Investors should monitor sector rotation between growth and value, commodity-price trends, and the durability of corporate free cash flow, all of which are likely to influence the fund's relative performance without determining its long-term quality-focused mandate.

Exploring Tickeron’s AI Screener for ETF Research

In my own analysis of funds like SCHD, I frequently rely on Tickeron’s AI Screener to quickly compare dividend ETFs against peers using technical indicators, fundamentals, and AI signals. It helps surface relevant patterns without spending hours on manual screens, which keeps my research process more efficient and focused on the metrics that matter most for income strategies.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHD

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


SCHD sees MACD Histogram just turned negative

SCHD saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 35 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SCHD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 31 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 64 cases where SCHD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHD as a result. In 59 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.

Bullish Trend Analysis

SCHD moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SCHD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.

Following a +1.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 265 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

SCHD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 283 of 364 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.

Notable companies

The most notable companies in this group are Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Home Depot (NYSE:HD), Texas Instruments (NASDAQ:TXN), Amgen (NASDAQ:AMGN), PepsiCo (NASDAQ:PEP), Abbott Laboratories (NYSE:ABT).

Industry description

The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100™ Index. To pursue its goal, the fund generally invests in stocks that are included in the index. The index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. The fund will invest at least 90% of its net assets in these stocks.

Market Cap

The average market capitalization across the Schwab US Dividend Equity ETF (SCHD) ETF is 57.94B. The market cap for tickers in the group ranges from 363.12M to 417.06B. CVX holds the highest valuation in this group at 417.06B. The lowest valued company is AMSF at 363.12M.

High and low price notable news

The average weekly price growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was 14%. For the same ETF, the average monthly price growth was 32%, and the average quarterly price growth was 130%. WEN experienced the highest price growth at 7%, while FLO experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was 21%. For the same stocks of the ETF, the average monthly volume growth was 8% and the average quarterly volume growth was -13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 42
Price Growth Rating: 45
SMR Rating: 42
Profit Risk Rating: 59
Seasonality Score: 12 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
CBRS fell -6.07% to $97.86 in the opening minutes of Wednesday's regular session, down from Tuesday's close of $104.18 — the move occurred during market hours, not premarket or after-hours. No verified news or fundamental catalyst found: no new filing, contract, or analyst action explains the drop, which is likely continued give-back from the post-earnings pop and the stock's habitual volatility — CBRS has averaged a ±4.5% daily swing over the past 60 sessions, and 17 of those sessions moved as much or more.
NVIDIA reported revenue of $115.84 billion for the third quarter of fiscal 2027, up 103% year over year and ahead of both company guidance and consensus estimates. Non-GAAP earnings per share (EPS, a measure of profit per outstanding share) came in at $2.68 , beating the roughly $2.47 analysts had expected.